The great strength of the PCWG3 is the recognition that second- , third- , and fourth-line treatments offer new possibilities for extending overall survival.
Rebecca Levine
Advertisement
Articles by Rebecca Levine
Advertisement
Latest Updated Articles
- Oslerian Genomics for Prostate Cancer Oncology
February 15th 2016
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Ruxolitinib Tablets for Hematologic Malignancies
2
Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
3
How Effective and Safe is EUS-Guided Alpha DaRT in Pancreatic Cancer?
4
SLN Surgery Omission Does Not Increase Radiotherapy Use in Breast Cancer
5